Researchers also noticed that the mice used as models for Alzheimer’s disease who were given stool transplants from healthy ...

The research paper, “APOLLOE4 Phase 3 Study of Oral ALZ-801/Valiltramiprosate in APOE ε4/ε4 Homozygotes with Early Alzheimer’s Disease: Trial Design & Baseline Characteristics,” was ...

Two new papers by a team of researchers at Boston University, the Indiana University School of Medicine and the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and the German Center for ...

FourNet & Alzheimer’s Society in the finals at European Contact Centre and Customer Service Awards 2024 to be held November ...

Analyst Andrew Fein from H.C. Wainwright reiterated a Buy rating on AC Immune SA (ACIU – Research Report) and keeping the price target at ...

New therapeutic opportunities often emerge from research on simple organisms. For instance, the 2020 Nobel Prize in Chemistry ...

(RTTNews) - INmune Bio, Inc. (INMB), Tuesday announced additional analysis of blinded data from AD02 Phase II Alzheimer's Disease, demonstrating exceptional performance of the novel cognitive measure ...

The following is a summary of “Association of vascular risk factors and cerebrovascular pathology with Alzheimer disease ...

Benefits of Walk to End Alzheimer's ...

A recent study by the University of California, Davis, suggests that a ketogenic diet may delay the progression of Alzheimer's disease. A key molecule elevated by ketogenic diets, beta-hydroxybutyrate ...

Paradigm Biopharmaceuticals says the FDA has endorsed key elements of its proposed phase III knee osteoarthritis trial.

Dr. Tilman explains the functions of iPSC-derived microglia and their relevance to conditions like Alzheimer’s.